Clinical Trials
2 trialsActive not recruiting × Metastatic Castration-Resistant Prostate Cancer (mCRPC) × 90 days × Clear all
NCT05806814 2026-05-27
OU-SCC-EXCITE
University of Oklahoma
Phase 1 Active not recruiting
NCT05658003 2026-03-23
A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis
Phase 2 Active not recruiting